companydata.dkcompanydata.dk

ESCO MEDICAL ApS: Financial statements 2022

CVR: 35383948

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

ESCO MEDICAL ApS (CVR 35383948) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 11,909,508 and a net result of DKK 1,424,026 compared with DKK 478,476 the year before. That is an increase of 44% compared with the year before. Equity in the 2022 report amounted to DKK 4,656,862. The solvency ratio was 87.9%. The company had 12 employees in the financial year.

Gross Profit
DKK 11,909,508
Profit/Loss
DKK 1,424,026
Equity
DKK 4,656,862
Total Assets
DKK 5,296,334
Employees
12

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-11.9M1.4M4.7M12
2021-8.3M478K1.9M9
2020-5.3M308K1.5M6
2019-5.5M293K1.2M6
2018-3.8M192K859K4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ESCO MEDICAL ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ESCO MEDICAL ApS: The 2021 annual report is outJun 29, 2022

ESCO MEDICAL ApS has published its annual report for 2021. Gross profit came to DKK 8,270,660, and the net result was DKK 478,476.

Lim Lay Yew joins ESCO MEDICAL ApS as adm. dir.Feb 22, 2022

As of February 22, 2022, Lim Lay Yew is registered as adm. dir. of ESCO MEDICAL ApS.

Lim Lay Yew steps down as adm. dir. of ESCO MEDICAL ApSFeb 21, 2022

As of February 21, 2022, Lim Lay Yew has stepped down as adm. dir. of ESCO MEDICAL ApS.

About ESCO MEDICAL ApS

ESCO MEDICAL ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2013. The company is registered under the industry Andre forretningsserviceaktiviteter i.a.n.. The company was previously named ESCO TECHNOLOGIES ApS. The management consists of Lim Lay Yew. The company is owned by Esco Technologies (Asia) Pte Ltd. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 9,048,924 and a net result of DKK 283,364 compared with DKK 459,851 the year before. Equity in the 2025 report amounted to DKK 5,935,374.

Source: annual report 2025, Danish Business Authority